Terms: = Prostate cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
23 results:
1. Impact of Asian Race on prognosis in De Novo Metastatic prostate cancer.
Ni X; Luu M; Ma W; Zhang T; Wei Y; Freedland SJ; Ye D; Daskivich TJ; Zhu Y
J Natl Compr Canc Netw; 2023 Jul; 21(7):733-741.e3. PubMed ID: 37433430
[TBL] [Abstract] [Full Text] [Related]
2. prognosis of male lung cancer patients with urinary cancer: a study from a national population-based analysis.
Li W; Cheng M; Hu P; Jiang L; Zhao X
Sci Rep; 2023 Jan; 13(1):283. PubMed ID: 36609573
[TBL] [Abstract] [Full Text] [Related]
3. Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.
Lundgren PO; Tribukait B; Kjellman A; Norming U; Jagarlmudi K; Gustafsson O
Prostate; 2022 Jun; 82(8):911-916. PubMed ID: 35294068
[TBL] [Abstract] [Full Text] [Related]
4. prognosis Associated With Luminal and Basal Subtypes of Metastatic prostate cancer.
Aggarwal R; Rydzewski NR; Zhang L; Foye A; Kim W; Helzer KT; Bakhtiar H; Chang SL; Perry MD; Gleave M; Reiter RE; Huang J; Evans CP; Alumkal JJ; Lang JM; Yu M; Quigley DA; Sjöström M; Small EJ; Feng FY; Zhao SG
JAMA Oncol; 2021 Nov; 7(11):1644-1652. PubMed ID: 34554200
[TBL] [Abstract] [Full Text] [Related]
5. Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study.
Thomsen FB; Garmo H; Brasso K; Egevad L; Stattin P
J Surg Oncol; 2021 Oct; 124(5):867-875. PubMed ID: 34145588
[TBL] [Abstract] [Full Text] [Related]
6. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
Rahmati Y; Alivand M; Mollanoori H
Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401
[TBL] [Abstract] [Full Text] [Related]
7. A novel imaging based Nomogram for predicting post-surgical biochemical recurrence and adverse pathology of prostate cancer from pre-operative bi-parametric MRI.
Li L; Shiradkar R; Leo P; Algohary A; Fu P; Tirumani SH; Mahran A; Buzzy C; Obmann VC; Mansoori B; El-Fahmawi A; Shahait M; Tewari A; Magi-Galluzzi C; Lee D; Lal P; Ponsky L; Klein E; Purysko AS; Madabhushi A
EBioMedicine; 2021 Jan; 63():103163. PubMed ID: 33321450
[TBL] [Abstract] [Full Text] [Related]
8. Patients' education level and treatment modality for prostate cancer in the Finnish Randomized Study of Screening for prostate cancer.
Kilpeläinen TP; Talala K; Taari K; Raitanen J; Kujala P; Pylväläinen J; Tammela TL; Auvinen A
Eur J Cancer; 2020 May; 130():204-210. PubMed ID: 32229417
[TBL] [Abstract] [Full Text] [Related]
9. A Prospective Study of Intraprostatic Inflammation, Focal Atrophy, and Progression to Lethal prostate cancer.
Zhang Y; Zhou CK; Rencsok EM; Fall K; Lotan TL; Loda M; Giunchi F; Platz EA; De Marzo AM; Mucci LA; Fiorentino M; Ebot EM
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2047-2054. PubMed ID: 31533941
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL.
Nam RK; Benatar T; Wallis CJD; Kobylecky E; Amemiya Y; Sherman C; Seth A
Prostate; 2019 Sep; 79(12):1422-1438. PubMed ID: 31269290
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of prostate cancer Stage Groups Updated in the 8th Edition of the American Joint Committee on cancer Tumor-Node-Metastasis Staging Manual.
Lee H; Lee M; Byun SS; Lee SE; Hong SK
Clin Genitourin Cancer; 2019 Feb; 17(1):e221-e226. PubMed ID: 30472041
[TBL] [Abstract] [Full Text] [Related]
12. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study.
Banke A; Schou M; Videbaek L; Møller JE; Torp-Pedersen C; Gustafsson F; Dahl JS; Køber L; Hildebrandt PR; Gislason GH
Eur J Heart Fail; 2016 Mar; 18(3):260-6. PubMed ID: 26751260
[TBL] [Abstract] [Full Text] [Related]
13. KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin [corrected] in prostate cancer models.
Gravina GL; Mancini A; Sanita P; Vitale F; Marampon F; Ventura L; Landesman Y; McCauley D; Kauffman M; Shacham S; Festuccia C
BMC Cancer; 2015 Dec; 15():941. PubMed ID: 26620414
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy.
Rodríguez-Berriguete G; Torrealba N; Ortega MA; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Guil-Cid M; Fraile B; Royuela M
BMC Cancer; 2015 Oct; 15():809. PubMed ID: 26507126
[TBL] [Abstract] [Full Text] [Related]
15. Socioeconomic inequalities in prostate cancer survival: A review of the evidence and explanatory factors.
Klein J; von dem Knesebeck O
Soc Sci Med; 2015 Oct; 142():9-18. PubMed ID: 26281022
[TBL] [Abstract] [Full Text] [Related]
16. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease.
García-González MA; Bujanda L; Quintero E; Santolaria S; Benito R; Strunk M; Sopeña F; Thomson C; Pérez-Aisa A; Nicolás-Pérez D; Hijona E; Carrera-Lasfuentes P; Piazuelo E; Jiménez P; Espinel J; Campo R; Manzano M; Geijo F; Pellise M; Zaballa M; González-Huix F; Espinós J; Titó L; Barranco L; Pazo-Cid R; Lanas A
Int J Cancer; 2015 Sep; 137(6):1362-73. PubMed ID: 25721731
[TBL] [Abstract] [Full Text] [Related]
17. High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.
Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Morita S; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
BMC Cancer; 2014 Sep; 14():717. PubMed ID: 25256077
[TBL] [Abstract] [Full Text] [Related]
18. Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases.
Batra J; O'Mara T; Patnala R; Lose F; Clements JA
Biol Chem; 2012 Dec; 393(12):1365-90. PubMed ID: 23667899
[TBL] [Abstract] [Full Text] [Related]
19. Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice.
Azmi AS; Aboukameel A; Bao B; Sarkar FH; Philip PA; Kauffman M; Shacham S; Mohammad RM
Gastroenterology; 2013 Feb; 144(2):447-456. PubMed ID: 23089203
[TBL] [Abstract] [Full Text] [Related]
20. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
Yoshimoto M; Ludkovski O; DeGrace D; Williams JL; Evans A; Sircar K; Bismar TA; Nuin P; Squire JA
Genes Chromosomes Cancer; 2012 Feb; 51(2):149-60. PubMed ID: 22045666
[TBL] [Abstract] [Full Text] [Related]
[Next]
